Ghost Tree Capital’s MacroGenics MGNX Stock Holding History

Ghost Tree Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-150,000	Closed	-$638K	–	67
2024 Q2	$638K	Buy	+150,000	New	+$1.46M	0.2%	57

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ghost Tree Capital's MGNX Position: Q3 2024 in Review

Ghost Tree Capital sold out of MacroGenics (MGNX) in Q3 2024, closing a stake of 150,000 shares — an estimated $638K sold.

Ghost Tree Capital first reported a position in MGNX in Q2 2024 and held it in 1 quarter. The position peaked at $638K in Q2 2024. 124 funds tracked by Wall St. Rank hold MGNX as of Q3 2024.

Ghost Tree Capital reported no remaining MacroGenics position as of Q3 2024 after selling out during the quarter.
Ghost Tree Capital sold 150,000 MacroGenics shares in Q3 2024, an estimated $638K.
Ghost Tree Capital first reported a position in MacroGenics in Q2 2024 and held it in 1 quarter.
Ghost Tree Capital's MacroGenics position peaked at $638K in Q2 2024.
124 funds tracked by Wall St. Rank held MacroGenics as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.